Exclusive

Publication

Byline

Jakarta police set parking areas for Palestine rally

Jakarta, Nov. 1 -- Jakarta police have designated five parking areas around the National Monument (Monas) in Central Jakarta for participants attending a mass rally marking Palestine Solidarity Month ... Read More


Sri Lanka, South Korea to sign MoUs on vocational training and student exchange programmes

SriLanka, Nov. 1 -- Sri Lanka is scheduled to enter into a new Memorandum of Understanding (MoU) with South Korea to implement vocational training and student exchange programmes. The Ministry of Lab... Read More


Agniveer Recruitment Rally : హైదరాబాద్‌లో నవంబర్ 13 నుండి 24 వరకు అగ్నివీర్ రిక్రూట్‌మెంట్ ర్యాలీ

భారతదేశం, నవంబర్ 1 -- తెలంగాణ రాష్ట్రంలోని నిరుద్యోగ యువతకు భారత సైన్యం గొప్ప అవకాశం కల్పించింది. 2027 రిక్రూట్‌మెంట్ సంవత్సరానికి గాను అగ్నివీర్ పోస్టుల భర్తీకి సంబంధించి భారీ రిక్రూట్‌మెంట్ ర్యాలీని... Read More


Rate hikes unlikely to push bond yields much higher: businessline poll

New Delhi, Nov. 1 -- India's benchmark 10-year government bond yield is unlikely to rise significantly from current levels even if the Reserve Bank of India raises the repo rate by another 50 basis po... Read More


Masussuka's killing highlights Nigeria's extremism, terrorism problem

Nigeria, Nov. 1 -- For some Nigerian Muslim fundamentalists, the killing of Yahaya Masussuka prompted relief rather than grief. The reaction highlights a troubling problem in Nigeria's religious and s... Read More


PSC report on release of 323 containers from Colombo Port to be released before Dec. 21

SriLanka, Nov. 1 -- The report of the Parliamentary Select Committee investigating the release of 323 containers from the Colombo Harbour is expected to be released before December 21, Minister Harsha... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-... Read More


Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabilit... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety o... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to E... Read More